Literature DB >> 20188645

Successful closure of left-to-right patent ductus arteriosus in three dogs with concurrent pulmonary hypertension.

Rachel L Seibert1, Herbert W Maisenbacher, Robert Prosek, Darcy B Adin, Wendy G Arsenault, Amara H Estrada.   

Abstract

Closure of reversed patent ductus arteriosus (PDA) is generally accepted to be contraindicated due to case based evidence of worsened outcomes, but little is known about closure of left-to-right PDA with concurrent pulmonary hypertension (PH). This report describes three dogs presenting with varying severity of PH and clinical signs, all with documented left-to-right PDA. The PDA was closed in each case; either by surgical ligation or transarterial device occlusion, and follow up was available for a minimum of 8 months. Every case had a successful outcome with improvement or resolution of PH and associated clinical signs. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20188645     DOI: 10.1016/j.jvc.2009.12.002

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  4 in total

1.  Pentoxifylline as adjunct therapy to long-term clinical management of a right-to-left patent ductus arteriosus.

Authors:  Elizabeth Turner
Journal:  Can Vet J       Date:  2016-06       Impact factor: 1.008

2.  Clinical Characteristics of Adult Dogs More Than 5 Years of Age at Presentation for Patent Ductus Arteriosus.

Authors:  B G Boutet; A B Saunders; S G Gordon
Journal:  J Vet Intern Med       Date:  2017-04-03       Impact factor: 3.333

3.  Measurement Variation and Repeatability of Echocardiographic Variables Used to Estimate Pulmonary Artery Pressure in Dogs.

Authors:  J A Abbott; J M Gentile-Solomon
Journal:  J Vet Intern Med       Date:  2017-10-14       Impact factor: 3.333

4.  ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.

Authors:  Carol Reinero; Lance C Visser; Heidi B Kellihan; Isabelle Masseau; Elizabeth Rozanski; Cécile Clercx; Kurt Williams; Jonathan Abbott; Michele Borgarelli; Brian A Scansen
Journal:  J Vet Intern Med       Date:  2020-02-17       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.